Research programme: HPMA copolymer platinates
Alternative Names: Cisplatin prodrugs - research programme; Copolymer platinates - research programme; Platinum polymer conjugates - research programmeLatest Information Update: 26 Apr 2002
At a glance
- Originator Nonindustrial source
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 03 Aug 1999 New profile
- 03 Aug 1999 Preclinical development for Cancer in United Kingdom (Unknown route)
- 03 Aug 1999 Preclinical development for Cancer in USA (Unknown route)